Cho‐Han Chiang

939 total citations
60 papers, 483 citations indexed

About

Cho‐Han Chiang is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Cho‐Han Chiang has authored 60 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 14 papers in Molecular Biology and 13 papers in Epidemiology. Recurrent topics in Cho‐Han Chiang's work include Cancer Immunotherapy and Biomarkers (12 papers), Diabetes Treatment and Management (11 papers) and Metabolism, Diabetes, and Cancer (6 papers). Cho‐Han Chiang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (12 papers), Diabetes Treatment and Management (11 papers) and Metabolism, Diabetes, and Cancer (6 papers). Cho‐Han Chiang collaborates with scholars based in Taiwan, United States and United Kingdom. Cho‐Han Chiang's co-authors include L.G. Doudeva, P.H. Kuo, Hanna S. Yuan, Cho‐Hung Chiang, Kevin Sheng‐Kai, Cheng‐Ming Peng, Chun-Yu Peng, Her‐Shyong Shiah, Li‐Tzu Wang and Tomas G. Neilan and has published in prestigious journals such as Nucleic Acids Research, Circulation and Journal of Clinical Oncology.

In The Last Decade

Cho‐Han Chiang

50 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cho‐Han Chiang Taiwan 10 187 99 97 76 68 60 483
Christine Bekos Austria 14 108 0.6× 54 0.5× 108 1.1× 25 0.3× 35 0.5× 36 418
Selçuk Dağdelen Türkiye 14 137 0.7× 50 0.5× 104 1.1× 46 0.6× 431 6.3× 82 738
Gael B. Morrow United Kingdom 10 75 0.4× 95 1.0× 53 0.5× 44 0.6× 16 0.2× 17 509
Robert Puckrin Canada 8 69 0.4× 50 0.5× 58 0.6× 14 0.2× 154 2.3× 29 370
Edith Bigot‐Corbel France 15 170 0.9× 13 0.1× 85 0.9× 42 0.6× 75 1.1× 54 575
James Tiesinga United States 11 184 1.0× 151 1.5× 175 1.8× 13 0.2× 87 1.3× 19 688
Fuxue Deng China 11 55 0.3× 66 0.7× 26 0.3× 38 0.5× 29 0.4× 22 376
Sandipan Chakraborty United States 10 106 0.6× 65 0.7× 56 0.6× 157 2.1× 9 0.1× 29 468
De Haas Netherlands 9 156 0.8× 28 0.3× 164 1.7× 121 1.6× 55 0.8× 19 562
Aura D. Herrera‐Martínez Spain 17 169 0.9× 212 2.1× 255 2.6× 30 0.4× 129 1.9× 67 729

Countries citing papers authored by Cho‐Han Chiang

Since Specialization
Citations

This map shows the geographic impact of Cho‐Han Chiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cho‐Han Chiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cho‐Han Chiang more than expected).

Fields of papers citing papers by Cho‐Han Chiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cho‐Han Chiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cho‐Han Chiang. The network helps show where Cho‐Han Chiang may publish in the future.

Co-authorship network of co-authors of Cho‐Han Chiang

This figure shows the co-authorship network connecting the top 25 collaborators of Cho‐Han Chiang. A scholar is included among the top collaborators of Cho‐Han Chiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cho‐Han Chiang. Cho‐Han Chiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Junmin, et al.. (2025). Risk for Cancer With Glucagon-Like Peptide-1 Receptor Agonists and Dual Agonists. Annals of Internal Medicine. 179(2). 216–229.
2.
Song, Junmin, Kuan-Yu Chi, Yu‐Ling Chang, et al.. (2025). Statin and Immune-Related Cardiovascular Events in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors. Oncology. 104(3). 319–326. 2 indexed citations
3.
4.
Jan, Yu Jen, et al.. (2024). Body mass index and type 2 diabetes mellitus as metabolic determinants of immune checkpoint inhibitors response in melanoma. Journal for ImmunoTherapy of Cancer. 12(11). e009769–e009769. 1 indexed citations
5.
6.
Chiang, Cho‐Hung, et al.. (2024). Impact of different corticosteroids on severe community-acquired pneumonia: a systematic review and meta-analysis. BMJ Open Respiratory Research. 11(1). e002141–e002141. 8 indexed citations
7.
Chi, Kuan‐Yu, et al.. (2024). Impact of sodium-glucose cotransporter-2 inhibitors on cardiovascular outcomes of prostate cancer patients receiving gonadotropin-releasing hormone agonists. European Journal of Preventive Cardiology. 33(4). 609–611. 4 indexed citations
8.
Chiang, Cho‐Han, et al.. (2024). Thromboprophylaxis for outpatients with COVID-19: a Systematic Review and Meta-analysis. Journal of Thrombosis and Thrombolysis. 57(5). 784–787.
9.
Chang, Yu‐Tzu, et al.. (2024). Dendritic cell vaccine for glioblastoma: an updated meta-analysis and trial sequential analysis. Journal of Neuro-Oncology. 170(2). 253–263.
10.
Chiang, Cho‐Han, et al.. (2024). Pancreatic cancer mortality trends in the United States: how much have we moved the needle?. Journal of Gastrointestinal Oncology. 15(4). 1789–1795. 2 indexed citations
11.
Chiang, Cho‐Han, Cho‐Hung Chiang, Mandy N. Lauw, et al.. (2024). Glucagon-like Peptide 1 Receptor Agonists Reduce the Risk of Venous Thromboembolism in Patients with Diabetes Irrespective of Obesity: A Propensity Score-Matched Multicenter Database Analysis. Blood. 144(Supplement 1). 701–701. 3 indexed citations
12.
Chiang, Cho‐Han, Junmin Song, Kuan‐Yu Chi, et al.. (2024). Glucagon-like Peptide‐1 Agonists Reduce Cardiovascular Events in Cancer Patients on Immune Checkpoint Inhibitors. European Journal of Cancer. 216. 115170–115170. 7 indexed citations
13.
Chiang, Cho‐Han, et al.. (2023). Effect of metformin on outcomes of patients treated with immune checkpoint inhibitors: a retrospective cohort study. Cancer Immunology Immunotherapy. 72(6). 1951–1956. 15 indexed citations
14.
15.
Chiang, Cho‐Han, et al.. (2023). Efficacy of Lipophilic Statins on Outcomes of Patients Treated with Immune Checkpoint Inhibitors. Oncology. 101(9). 537–541. 5 indexed citations
16.
17.
18.
Chiang, Cho‐Han, Cho‐Hung Chiang, Kevin Sheng‐Kai, et al.. (2022). Impact of sodium-glucose cotransporter-2 inhibitors on heart failure and mortality in patients with cancer. Heart. 109(6). 470–477. 40 indexed citations
19.
Chiang, Cho‐Han, Cho‐Hung Chiang, Kevin Sheng‐Kai, et al.. (2022). The incidence and risk of cardiovascular events associated with immune checkpoint inhibitors in Asian populations. Japanese Journal of Clinical Oncology. 52(12). 1389–1398. 21 indexed citations
20.
Chiang, Cho‐Han, Sung‐Ching Pan, Keisuke Matsuda, et al.. (2018). Healthcare-associated infections in intensive care units in Taiwan, South Korea, and Japan: recent trends based on national surveillance reports. Antimicrobial Resistance and Infection Control. 7(1). 129–129. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine Bekos Breakdown of academic impact, for papers by Selçuk Dağdelen Breakdown of academic impact, for papers by Gael B. Morrow Breakdown of academic impact, for papers by Robert Puckrin Breakdown of academic impact, for papers by Edith Bigot‐Corbel Breakdown of academic impact, for papers by James Tiesinga Breakdown of academic impact, for papers by Fuxue Deng Breakdown of academic impact, for papers by Sandipan Chakraborty Breakdown of academic impact, for papers by De Haas Breakdown of academic impact, for papers by Aura D. Herrera‐Martínez
Rankless by CCL
2026